Definium Therapeutics, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Definium Therapeutics, Inc. (DFTX) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $9.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $9.00K.
- 2026-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $74.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $330.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $251.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $74.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $330.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $251.00K 10-Q · filed 2025-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |